Cheplapharm looks for €9bn valuation in first jumbo IPO of the year
GlobalCapital, is part of the Delinian Group, DELINIAN (GLOBALCAPITAL) LIMITED, 4 Bouverie Street, London, EC4Y 8AX, Registered in England & Wales, Company number 15236213
Copyright © DELINIAN (GLOBALCAPITAL) LIMITED and its affiliated companies 2024

Accessibility | Terms of Use | Privacy Policy | Modern Slavery Statement
Cookies Settings
EquityEquity IPOs

Cheplapharm looks for €9bn valuation in first jumbo IPO of the year

Victoria Thiele
January 17, 2022 04:34 PM
Pharmaceutical representative, consultant or head director or manager of medicine company with white tablets. Man in a suit pouring spilling pills.

German pharmaceuticals platform breaks the ice for large cap listings in Europe this year

Unlock this article.

The content you are trying to view is exclusive to our subscribers.

To unlock this article:

Request a Free Trial or Login

Topics

JP MorganDeutsche BankCredit SuisseBarclaysCitiGermanyEquityHealth and Biotech
VT
Victoria Thiele
Senior Reporter - CLOs
Contact
Gift this article